Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms

CM Friedenreich, C Ryder‐Burbidge… - Molecular …, 2021 - Wiley Online Library
An estimated 30–40% of cancers can be prevented through changes in modifiable lifestyle
and environmental risk factors known to be associated with cancer incidence. Despite this …

The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion

P De Cicco, G Ercolano, A Ianaro - Frontiers in immunology, 2020 - frontiersin.org
Suppression of antitumor immune responses is one of the main mechanisms by which tumor
cells escape from destruction by the immune system. Myeloid-derived suppressor cells …

Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis

N Pernigoni, E Zagato, A Calcinotto, M Troiani… - Science, 2021 - science.org
The microbiota comprises the microorganisms that live in close contact with the host, with
mutual benefit for both counterparts. The contribution of the gut microbiota to the emergence …

The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery

NA di Meo, F Lasorsa, M Rutigliano… - Expert Review of …, 2023 - Taylor & Francis
Introduction Lipidomics focuses on the in-depth analysis of lipids, which are crucial
macromolecules involved in a wide range of metabolic pathways. The increased …

Niclosamide: Beyond an antihelminthic drug

W Chen, RA Mook Jr, RT Premont, J Wang - Cellular signalling, 2018 - Elsevier
Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of
people worldwide. However recent studies have indicated that niclosamide may have broad …

WNT signalling in prostate cancer

V Murillo-Garzón, R Kypta - Nature Reviews Urology, 2017 - nature.com
Genome sequencing and gene expression analyses of prostate tumours have highlighted
the potential importance of genetic and epigenetic changes observed in WNT signalling …

The tumor immune contexture of prostate cancer

N Vitkin, S Nersesian, DR Siemens, M Koti - Frontiers in immunology, 2019 - frontiersin.org
One in seven men in North America is expected to be diagnosed with prostate cancer (PCa)
during their lifetime (,). While a wide range of treatment options including surgery, radiation …

Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis

L Meng, Y Yang, X Hu, R Zhang, X Li - Journal of translational medicine, 2023 - Springer
Background The systemic immune-inflammation index (SII) is a novel biomarker to predict
the prognosis of some malignant tumors based on neutrophil, platelet, and lymphocyte …

[HTML][HTML] Development and prevalence of castration-resistant prostate cancer subtypes

JE Vellky, WA Ricke - Neoplasia, 2020 - Elsevier
Background Castration-resistant prostate cancer (CRPC) occurs when prostate cancer
(CaP) progresses under therapy-induced castrate conditions. Several mechanisms have …

Loss and revival of androgen receptor signaling in advanced prostate cancer

N Formaggio, MA Rubin, JP Theurillat - Oncogene, 2021 - nature.com
Targeting the androgen receptor (AR) signaling axis has been, over decades, the mainstay
of prostate cancer therapy. More potent inhibitors of androgen synthesis and antiandrogens …